Recent studies also suggest that elevated levels of IL-6 and TNF-α assessed on days 1 and 7 significantly correlate with greater stroke severity and worse functional outcomes, as indicated by higher NIHSS and mRS scores. This evidence concerns the gene IL6 and stroke disorder.